Post by MicroPort

79,792 followers

How can DAPT duration be personalized after PCI? Prof. Gilles Montalescot shares his perspective on the TARGET-FIRST trial, recently recognized as a landmark study by the European Heart Journal, and how its findings support a more personalized approach to antiplatelet therapy for carefully selected AMI patients. šŸŽ„ Watch the full interview : https://lnkd.in/eDSuPhi4 Follow #TARGETFIRSTPerspectives for expert voices from Europe, Asia, and the Americas on what TARGET-FIRST means for everyday clinical practice. #ShortDAPT #TargetFirst #PCI #InterventionalCardiology

Post content

Video Content